Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Clinical trial NCT03570892 · COMPLETED
Trial details
- NCT number
- NCT03570892
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-09
- Primary completion
- 2021-05-06
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.